Cancer Res Treat.
2019 Jul;51(3):1257-1257. 10.4143/crt.2015.227.2.
ERRATUM: Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms
- Affiliations
-
- 1Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
- 2Division of Radiation Cancer Biology, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
- 3Department of Pathology, Korea University College of Medicine, Seoul, Korea.
- KMID: 2454317
- DOI: http://doi.org/10.4143/crt.2015.227.2
Abstract
- For the data represented in Fig. 4B, we have generated a new figure from one of these repeat experiments.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms
- Cell Death Induction Mechanism of Non-small Cell Lung Cancer Cell Line, NCI-H1703 by Docetaxel
- Caveolin-1 is involved in high glucose accelerated human glomerular mesangial cell senescence
- Increased Expression of Caveolin-1 in Renal Cell Carcinoma
- Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
